(Q33959573)

30 July 2017

0 references

1 reference

title

Incidence of liver toxicity in inflammatory bowel disease patients treated with methotrexate: a meta-analysis of clinical trials (English)

1 reference

inflammatory bowel diseases

30 July 2017

main subject

0 references

1 reference

1 reference

5

Lydia A Bazzano

1 reference

30 July 2017

6

Tanika N Kelly

1 reference

30 July 2017

4

Luis A Balart

1 reference

30 July 2017

Nabeel Khan

1

1 reference

30 July 2017

Ali M Abbas

series ordinal

2

1 reference

30 July 2017

Naree Whang

series ordinal

3

1 reference

30 July 2017

publication date

12 July 2011

1 reference

Inflammatory Bowel Diseases

30 July 2017

published in

1 reference

30 July 2017

volume

18

1 reference

30 July 2017

issue

2

1 reference

30 July 2017

page(s)

359-367

1 reference

Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences

30 July 2017

cites work

1 reference

Hepatotoxicity rates do not differ in patients with rheumatoid arthritis and psoriasis treated with methotrexate

21 January 2018

1 reference

Methotrexate and psoriasis: 2009 National Psoriasis Foundation Consensus Conference

21 January 2018

1 reference

Multinational evidence-based recommendations for the use of methotrexate in rheumatic disorders with a focus on rheumatoid arthritis: integrating systematic literature research and expert opinion of a broad international panel of rheumatologists in t

21 January 2018

1 reference

Changes in liver biochemistry during methotrexate use for inflammatory bowel disease

21 January 2018

1 reference

Criteria of drug-induced liver disorders. Report of an international consensus meeting

21 January 2018

1 reference

Comparison between methotrexate and azathioprine in the treatment of chronic active Crohn's disease: a randomised, investigator-blind study

21 January 2018

1 reference

Low-dose oral methotrexate in refractory inflammatory bowel disease

21 January 2018

1 reference

Azathioprine or methotrexate in the treatment of patients with steroid-dependent or steroid-resistant ulcerative colitis: results of an open-label study on efficacy and tolerability in inducing and maintaining remission

21 January 2018

1 reference

Combining infliximab and methotrexate in fistulizing Crohn's disease resistant or intolerant to azathioprine.

21 January 2018

1 reference

Combining infliximab with methotrexate for the induction and maintenance of remission in refractory Crohn's disease: a controlled pilot study.

21 January 2018

1 reference

Quantifying heterogeneity in a meta-analysis

21 January 2018

1 reference

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

21 January 2018

1 reference

Thiopurine-induced liver injury in patients with inflammatory bowel disease: a systematic review

21 January 2018

1 reference

Incidence, risk factors and clinical course of thiopurine-induced liver injury in patients with inflammatory bowel disease

21 January 2018

1 reference

Adverse events leading to modification of therapy in a large cohort of patients with inflammatory bowel disease.

21 January 2018

1 reference

Methotrexate for the Treatment of Crohn's Disease

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IBD.21820

1 reference

30 July 2017

1 reference